These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7282220)

  • 1. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic and cholinergic influences on motor behavior in chickens.
    Sanberg PR
    J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
    Shannon HE; Peters SC
    J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.
    Fink H; Morgenstern R
    Psychopharmacology (Berl); 1985; 85(4):464-8. PubMed ID: 2991961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LSD-potentiated apomorphine hypermotility: a model for differentiating antipsychotic drugs.
    Morgenstern R; Fink H; Oelssner W
    Pharmacol Biochem Behav; 1983 Jan; 18(1):13-7. PubMed ID: 6681904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atypical antidepressants on LSD potentiated apomorphine hypermotility in rats.
    Gold R; Morgenstern R; Fink H
    Acta Biol Med Ger; 1980; 39(8-9):917-21. PubMed ID: 6456637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens.
    Morgenstern R; Mende T; Gold R; Lemme P; Oelssner W
    Pharmacol Biochem Behav; 1984 Oct; 21(4):501-6. PubMed ID: 6504948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kainic acid induced lesion of ventral tegmental area: locomotor effect of apomorphine.
    Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):911-5. PubMed ID: 7282221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some central effects of angiotensin II. Interactions with dopaminergic transmission.
    Georgiev V; György L; Getova D; Markovska V
    Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
    Burkard WP; Pieri L; Haefely W
    Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic and cholinergic influences on morphine self-administration in rats.
    Glick SD; Cox RD
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):17-24. PubMed ID: 1188183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
    Morgenstern R; Fink H
    J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of serotoninergic mechanisms in the circling behaviour induced by apomorphine and LSD 25 in rats (author's transl)].
    Jaton AL; Vigouret JM; Dravid A
    J Physiol (Paris); 1981; 77(2-3):405-11. PubMed ID: 7288655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity.
    Carey RJ; DePalma G; Damianopoulos E; Hopkins A; Shanahan A; Müller CP; Huston JP
    Brain Res; 2004 Sep; 1019(1-2):134-43. PubMed ID: 15306247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
    Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.